UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

The lancet oncology, 2013-06, Vol.14 (7), p.609-618

2013

Volltextzugriff (PDF)

Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)

Breast (Edinburgh), 2020-08, Vol.52, p.110-115

2020

Volltextzugriff (PDF)

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

Modern pathology, 2015-09, Vol.28 (9), p.1185-1201

2015

Volltextzugriff (PDF)

Editorial: Eur J Surg Oncol 2021. Debate on chest wall irradiation for patients wir 1–3 pos lymph nodes: Do we ask the right question?

European journal of surgical oncology, 2021-10, Vol.47 (10), p.2481-2482

Kuehn, Thorsten

2021

Volltextzugriff (PDF)

Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future

Radiologia medica, 2024-02, Vol.129 (2), p.315-327

2024

Volltextzugriff (PDF)

The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis

Cancers, 2021-03, Vol.13 (6), p.1391

2021

Volltextzugriff (PDF)

Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study

Breast cancer (Tokyo, Japan), 2022-05, Vol.29 (3), p.429-436

2022

Volltextzugriff (PDF)

Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials

Cancers, 2021-04, Vol.13 (9), p.2056

2021

Volltextzugriff (PDF)

What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of view

EClinicalMedicine, 2021-01, Vol.31, p.100708-100708, Article 100708

2021

Volltextzugriff (PDF)

Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II

Breast cancer (Tokyo, Japan), 2017-03, Vol.24 (2), p.281-287

2017

Volltextzugriff (PDF)

Should we worry about residual disease after mastectomy?

The lancet oncology, 2020-08, Vol.21 (8), p.1011-1013

2020

Volltextzugriff (PDF)

Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors

Breast cancer research and treatment, 2000-12, Vol.64 (3), p.275-286

2000

Volltextzugriff (PDF)

Lymph Node Management in Breast Cancer: A Highly Dynamic Evolution

Breast care (Basel, Switzerland), 2018-10, Vol.13 (5), p.320-322

Kühn, Thorsten

2018

Volltextzugriff (PDF)

Axillary Surgery in Ductal Carcinoma In Situ

Chirurgia (Bucharest, Romania : 1990), 2021-12, Vol.116 (5 Suppl), p.S140-S142

Kuhn, Thorsten

2021

Volltextzugriff (PDF)

The forgotten node: Axillary surgery mandates expertise

European journal of surgical oncology, 2022-09, Vol.48 (9), p.1922-1924

2022

Volltextzugriff (PDF)

Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis

British journal of surgery, 2023-03, Vol.110 (4), p.410-419

2023

Volltextzugriff (PDF)

Breast Cancer: Diagnostic Imaging and Therapeutic Guidance

Uwe Fischer, Friedemann Baum, Susanne Luftner-Nagel

2017

Volltextzugriff (PDF)

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Journal of clinical oncology, 2011-09, Vol.29 (25), p.3351-3357

2011

Volltextzugriff (PDF)

Abstract P1-01-16: Perspectives on axillary management after primary systemic treatment: An international EUBREAST survey

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-01-16

2022

Volltextzugriff (PDF)

Updates in the treatment of ductal carcinoma in situ of the breast

Current opinion in obstetrics & gynecology, 2016-02, Vol.28 (1), p.49

2016

Volltextzugriff (PDF)

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Journal of clinical oncology, 2010-04, Vol.28 (12), p.2024-2031

2010

Volltextzugriff (PDF)

1 – 25 von 494

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(449)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Deutsch
(264)
Englisch
(226)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

Editorial: Eur J Surg Oncol 2021. Debate on chest wall irradiation for patients wir 1–3 pos lymph nodes: Do we ask the right question?

Optimising of axillary therapy in breast cancer: lessons from the past to plan for a better future

The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis

Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study

Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials

Assessing variability in breast cancer management across the world: results of a questionnaire survey amongst global international experts in breast cancer management

What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of view

Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II

Should we worry about residual disease after mastectomy?

Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors

Lymph Node Management in Breast Cancer: A Highly Dynamic Evolution

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients

Axillary Surgery in Ductal Carcinoma In Situ

The forgotten node: Axillary surgery mandates expertise

Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis

Breast Cancer: Diagnostic Imaging and Therapeutic Guidance

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

Abstract P1-01-16: Perspectives on axillary management after primary systemic treatment: An international EUBREAST survey

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial

Updates in the treatment of ductal carcinoma in situ of the breast

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Suchergebnisse filtern